I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $118.94
    -1.31 (-1.09%)

    Market Cap: $3.96B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(22/40)
    Avg Surprise
    +167.47%
    Streak
    5 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.04
    Range$-0.08 - $0.14
    11 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$0.09+112.6%
    60d ago$0.09+112.6%
    30d ago$0.09+107.1%
    7d ago$0.04+0.0%
    Current$0.04
    Revenue Consensus
    $222M
    Range$222M - $225M
    15 analysts
    Dec 31, 2026
    EPS Consensus$1.19
    Range$0.98 - $1.38
    10 analysts
    Revenue Consensus
    $251M
    Range$249M - $254M
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.19---
    Sep 26EST
    		-$0.04---
    Jun 26
    		$0.58$-0.01+5900.00%Beat+281.2%
    Mar 26
    		$-0.35$-0.64+45.31%Beat+63.2%
    Dec 25
    		$0.17$0.01+1600.00%Beat+1600.0%
    Sep 25
    		$-0.06N/A+78.57%Beat+95.2%
    Jun 25
    		$-0.32$-0.47+31.91%Beat+47.5%
    Mar 25
    		$-0.95$-0.94-1.06%Miss+22.8%
    Dec 24
    		$0.01N/A+103.57%Beat+100.8%
    Sep 24
    		$-1.26$-0.57-121.05%Miss-59.5%
    Jun 24
    		$-0.61$-0.88+30.68%Beat-41.9%
    Mar 24
    		$-1.23$-0.99-24.24%Miss-11.8%
    Dec 23
    		$-1.26$-0.60-110.00%Miss-88.1%
    Sep 23
    		$-0.79$-0.58-36.21%Miss-25.4%
    Jun 23
    		$-0.43$-0.75+42.67%Beat+45.6%
    Mar 23
    		$-1.10$-0.86-27.91%Miss-37.5%
    Dec 22
    		$-0.67$-0.62-8.06%Miss+39.1%
    Sep 22
    		$-0.63$-0.81+22.22%Beat+22.2%
    Jun 22
    		$-0.79$-0.90+12.22%Beat-33.9%
    Mar 22
    		$-0.80$-1.06+24.53%Beat+15.8%
    Dec 21
    		$-1.10$-1.17+5.98%Beat-233.3%
    Sep 21
    		$-0.81$-1.07+24.30%Beat-376.5%
    Jun 21
    		$-0.59$-0.94+37.23%Beat+21.3%
    Mar 21
    		$-0.95$-0.85-11.76%Miss-179.4%
    Dec 20
    		$-0.33$-0.31-6.45%Miss+49.2%
    Sep 20
    		$-0.17N/A+67.31%Beat+77.0%
    Jun 20
    		$-0.75$-0.75+0.00%Beat-63.0%
    Mar 20
    		$-0.34$-0.59+42.37%Beat-3.0%
    Dec 19
    		$-0.65$-0.50-30.00%Miss-35.4%
    Sep 19
    		$-0.74$-0.39-89.74%Miss-72.1%
    Jun 19
    		$-0.46$-0.44-4.55%Miss+9.8%
    Mar 19
    		$-0.33$-0.48+31.25%Beat+29.8%
    Dec 18
    		$-0.48$-0.45-6.67%Miss+0.0%
    Sep 18
    		$-0.43$-0.45+4.44%Beat-48.3%
    Jun 18
    		$-0.51$-0.39-30.77%Miss-75.9%
    Mar 18
    		$-0.47$-0.36-30.56%Miss-95.8%
    Dec 17
    		$-0.48$-0.35-37.14%Miss-29.7%
    Sep 17
    		$-0.29$-0.32+9.38%Beat+89.6%
    Jun 17
    		$-0.29$-0.29+0.00%Beat-
    Mar 17
    		$-0.24$-0.35+31.43%Beat-
    Dec 16
    		$-0.37$-0.27-37.04%Miss-
    Sep 16
    		$-2.80$-0.30-833.33%Miss-

    Key Metrics

    Valuation
    P/E Ratio349.82EV/EBITDA149.57x
    Price/FCF100.38xFCF Yield1.00%
    Profitability
    Profit Margin-1.69%Operating Margin7.94%
    ROE-9.63%ROIC-2.48%
    Financial Health
    Debt/Equity3.50xInterest Coverage-1.57x
    Current Ratio3.85xQuick Ratio3.74x
    Trading Statistics
    Beta1.32Avg Volume674.14K
    52-Week High$212.0052-Week Low$100.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$121.95
    SMA 20$123.28
    SMA 50$119.07
    SMA 200$135.68
    EMA 10$121.11
    EMA 20$121.30
    EMA 50$119.80
    EMA 200$129.01

    MACD

    Line: 0.35Signal: 1.27Hist: -0.92

    ADX

    ADX: 18.4+DI: 19.0-DI: 21.2

    Aroon & PSAR

    Aroon Up36.0
    Aroon DownN/A
    PSAR$126.66

    Bollinger Bands

    Upper Band$131.66
    Lower Band$114.91
    %B Position1359%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    47.7

    Momentum Oscillators

    Stoch %K23.7
    Stoch %D22.3
    Williams %R-73.4
    ROC (10d)1.7%
    Momentum2.02
    CCI (20d)-109.6
    MFI (14d)56.0

    Volatility Measures

    ATR (14d)$5.69(4.8%)
    StdDev (20d)4.19
    Hist Vol53.7%(High)

    Volume Flow

    VWAP$118.21
    OBV1.5M
    AD Line-118.7K
    CMF (20d)0.023

    Volume Metrics

    Avg Vol (20d)672.6K
    Vol Ratio0.7x
    VWMA (20d)$124.10

    Pivot Points

    R3$128.78
    R2$124.99
    R1$122.62
    Pivot Point$118.83
    S1$116.46
    S2$112.67
    S3$110.30

    Advanced Oscillators

    TSI1.72
    Ultimate Osc46.3
    KST29.36

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$224.17M$199.39M$208.89M$192.88M$186.69M$158.68M$164.32M$147.54M$148.05M$131.93M$132.51M$124.60M
    Cost of Revenue$60.97M$58.04M$60.84M$55.76M$53.83M$49.46M$49.26M$46.06M$44.58M$44.41M$45.09M$42.13M
    Gross Profit$163.21M$141.35M$148.06M$137.12M$132.86M$109.22M$115.07M$101.48M$103.47M$87.52M$87.43M$82.47M
    Operating Expenses$165.75M$157.54M$145.77M$145.55M$151.56M$141.77M$119.15M$151.78M$126.45M$125.65M$126.61M$110.08M
    R&D$20.14M$21.65M$21.79M$21.34M$22.71M$21.82M$19.38M$47.76M$19.69M$16.99M$15.42M$16.31M
    SG&A$131.66M$135.88M$122.00M$124.22M$126.38M$119.96M$99.77M$103.38M$106.76M$108.66M$100.11M$93.77M
    Operating Income$-2,542,000$-16,185,000$2.29M$-8,429,000$-18,708,000$-32,556,000$-4,083,000$-50,303,000$-22,981,000$-38,138,000$-39,182,000$-27,603,000
    Interest Income$4.78M$4.88M$5.34M$5.94M$5.32M$4.92M$5.74M$6.46M$6.68M$3.06M$0$1.72M
    Interest Expense$3.29M$3.29M$3.32M$3.28M$3.28M$3.27M$3.32M$3.33M$3.31M$10.45M$941,000$927,000
    Income Before Tax$-381,000$-13,433,000$6.03M$-5,188,000$-14,401,000$-30,035,000$-1,182,000$-45,994,000$-19,913,000$-45,635,000$-38,444,000$-26,921,000
    Income Tax Expense$0$500,000$447,000$24,000$-183,000$665,000$151,000$188,000$194,000$32,000$255,000$195,000
    Net Income$-381,000$-13,933,000$5.58M$-5,212,000$-14,218,000$-30,700,000$-1,333,000$-46,182,000$-20,107,000$-45,667,000$-38,699,000$-27,116,000
    EBITDA$4.89M$-8,398,000$10.53M$-1,376,000$-9,800,000$-24,903,000$3.51M$-41,967,000$-16,375,000$-32,198,000$-37,082,000$-23,562,000
    EBIT$-1,863,000$-15,022,000$4.01M$-7,851,000$-16,444,000$-31,681,000$-3,602,000$-49,121,000$-23,286,000$-38,243,000$-42,139,000$-27,711,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRTC

    News

    Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

    Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (IRTC) for corporate wrongdoing. The firm encourages investors who purchased iRhythm securities before January 11, 2022, and still hold them, to contact them to assist in the securities investigation. The firm operates on a contingency fee basis, meaning investors incur no upfront cost.

    ACCESS Newswire•8/23/26•
    Bearish

    Freedom Capital cuts iRhythm Technologies stock price target on valuation By Investing.com

    Freedom Capital has lowered its price target for iRhythm Technologies (NASDAQ: IRTC) to $190 from $200, while maintaining a Buy rating, citing the stock's overvaluation despite strong Q2 results. The company reported impressive revenue growth and increased its fiscal 2026 EBITDA guidance, also expanding its portfolio with the acquisition of VitalConnect. Analysts still anticipate profitability for iRhythm this year, with further product approvals expected in early 2027.

    Investing.com Nigeria•8/21/26•
    Neutral

    Freedom Capital cuts iRhythm Technologies stock price target on valuation By Investing.com

    Freedom Capital has lowered its price target for iRhythm Technologies (NASDAQ:IRTC) shares from $200 to $190, while maintaining a Buy rating. This adjustment comes despite iRhythm exceeding second-quarter revenue and EBITDA expectations, with strong growth and improved profitability. The firm cited valuation as the reason for the target cut, noting the stock appears overvalued relative to its Fair Value estimate.

    Investing.com Canada•8/20/26•
    Neutral

    William Blair Maintains IRhythm Technologies(IRTC.US) With Buy Rating

    William Blair analyst Brandon Vazquez has maintained a "Buy" rating on iRhythm Technologies (IRTC.US). Vazquez has a 41.8% success rate and a -2.5% average return over the past year, according to TipRanks data. The article includes disclaimers that the information is for educational purposes only and not investment advice.

    Moomoo•8/20/26•
    Bullish

    Citizens Financial Group Inc. RI Buys New Shares in iRhythm Technologies $IRTC

    Citizens Financial Group Inc. RI has acquired a new stake of 48,960 shares in iRhythm Technologies, valued at approximately $9.29 million, representing about 0.15% of the company. Despite recent target-price reductions, analysts maintain a "Moderate Buy" consensus with an average price target of $179.93 for IRTC. iRhythm Technologies also reported strong quarterly results, with revenue up 20.1% year over year and earnings per share beating analyst expectations.

    MarketBeat•8/18/26•
    Somewhat-Bullish

    Frequently Asked Questions About IRTC

    Does IRTC pay dividends?
    iRhythm Technologies Inc (IRTC) does not currently pay a regular dividend.
    What is IRTC's P/E ratio?
    iRhythm Technologies Inc has a price-to-earnings (P/E) ratio of 349.82.
    What is IRTC's market cap?
    iRhythm Technologies Inc (IRTC) has a market capitalization of $3.96B with a current stock price of $118.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In